Heck Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,558
Closed -$271K 225
2025
Q4
$271K Buy
2,558
+20
+0.8% +$1.88K 0.02% 199
2025
Q3
$215K Buy
2,538
+12
+0.5% +$988 0.02% 191
2025
Q2
$202K Buy
2,526
+2,261
+853% +$180K 0.02% 177
2025
Q1
$23.8K Sell
265
-9,923
-97% -$926K ﹤0.01% 189
2024
Q4
$1.01M Buy
10,188
+9,933
+3,895% +$1.02M 0.04% 138
2024
Q3
$29K Hold
255
﹤0.01% 171
2024
Q2
$31.6K Hold
255
﹤0.01% 165
2024
Q1
$33.6K Hold
255
0.01% 162
2023
Q4
$27.8K Hold
255
﹤0.01% 159
2023
Q3
$26.3K Buy
+255
New +$27.5K ﹤0.01% 154

Other funds holding MRK

Heck Capital Advisors's MRK Position: Q1 2026 in Review

Heck Capital Advisors sold out of Merck (MRK) in Q1 2026, closing a stake of 2,558 shares — an estimated $271K sold.

Heck Capital Advisors first reported a position in MRK in Q3 2023 and held it in 10 quarters. The position peaked at $1.01M in Q4 2024. 3,800 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Heck Capital Advisors reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Heck Capital Advisors sold 2,558 Merck shares in Q1 2026, an estimated $271K.
  • Heck Capital Advisors first reported a position in Merck in Q3 2023 and held it in 10 quarters.
  • Heck Capital Advisors's Merck position peaked at $1.01M in Q4 2024.
  • 3,800 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Heck Capital Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.